Immunotherapy in CRPC - James Gulley

August 29, 2013

Immunotherapy Castration-resistant Prostate Cancer: What do we know and Clinical Applications

Dr. James Gulley discusses immunotherapy for prostate cancer, including how therapeutic vaccines work, examples of therapeutic vaccines in mCRPC, appropriate patient populations to treat with immunotherapy, and immune checkpoint inhibitors.

James L. Gulley, MD, PhD, FACP - BIO